Trial Profile
A study investigating the effect of folate immune given with interferon-alpha and interleukin 2 in patients with renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Folate-fluorescein isothiocyanate conjugate (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 09 Dec 2015 New trial record